H.R. 4966
Referred to CommitteePreventing Superbugs and Protecting Patients Act
Introduced 4/15/2016•114th Congress•House
Latest Action
Referred to the Subcommittee on Health.
4/22/2016 • House
Summary
Preventing Superbugs and Protecting Patients Act
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to identify types of medical devices for which premarket notification must include proposed labeling, including validated instructions regarding cleaning, disinfection, and sterilization.
The FDA must issue final guidance regarding when a premarket notification is required for a modification to a medical device.Introduced in House • 4/15/2016
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)Government information and archivesHealth technology, devices, suppliesInfectious and parasitic diseases
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (9)
Party Breakdown
8
Democrats
1
Republicans
0
Independents
Sponsor
R[
Cosponsors (8)
R[
DL
R[
R[
R[
R[
Bill Journey
Originated in the House
Introduced
April 15, 2016
Referred to the House Committee on Energy and Commerce.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House4/15/2016